Flonase Antitrust Claims Survive GSK's Dismissal Bid
A judge has denied GlaxoSmithKline PLC's request to dismiss an antitrust suit over the drug Flonase, finding that the plaintiff, generic-drug maker Roxane Laboratories Inc., was able to sufficiently allege that...To view the full article, register now.
Already a subscriber? Click here to view full article